Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution.
Claire FordeAndrew T KingScott A RutherfordCharlotte Hammerbeck-WardSimon K LloydSimon R FreemanOmar N PathmanabanEmma StapletonOwen M ThomasRoger D LaittStavros StivarosJohn-Paul KildayGrace VassalloCatherine McBainSimon KerriganMiriam J SmithMartin G McCabeElaine F HarknessD Gareth EvansPublished in: Neuro-oncology (2021)
Understanding disease course improves prognostication, allowing for better-informed decisions about care.